Home
Home

A leading investment firm focused on structured financings of commercialized biopharmaceutical products and medical technologies.

Contact

AFT Pharmaceuticals Closes Important Financing To Spur Global Growth

May 19, 2014 – Innovative Australasian pharmaceutical sales and development company, AFT Pharmaceuticals Ltd (AFT), has finalised an equity and structured debt funding package with Capital Royalty Partners (Houston, Boulder, New York) and equity funding with New Zealand-based Milford Asset Management (Auckland) though the Milford Active Growth Fund.

Structured Debt Primer

Several consistent features make Structured Debt a compelling option when compared to traditional sources of capital; these include: (1) access to long-term capital on flexible, customizable terms, (2) a competitive cost of capital with limited equity dilution, and (3) straightforward transaction execution processes. The purpose of this white paper is to introduce Structured Debt, provide an overview of the increasingly important role it plays in capital markets, identify companies and situations for which it is best suited, and discuss its key terms, variations, and advantages from the perspective of a growth-stage company.